AvientAVNT
AVNT logo
Fair Value
US$34
Share price10 Jan
US$36.036.0% overvalued intrinsic discount
Loading
1Y7.26%
7D-7.35%

Healthcare And Defense Materials Will Steadily Support A Fairly Valued Long Term Outlook

Analyst Low Target compiles bearish analysts opinions to create narratives which represent one standard deviation below the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
10 Jan 26
Views
17
Not Invested

Fair Value vs Share Price

US$34
vs US$36.036.0% overvalued intrinsic discount
PastFuture04b2015201820212024202620272029Revenue US$3.4bEarnings US$282.4m
2%
Revenue growth
8.2%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Avient

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Very undervalued established dividend payer.

Market capUS$3.3b
PB1.4x
Estimated Growth3.8%
Dividend Yield3.1%
Full analysis

CEO & management

Ashish Khandpur
CEO
2.0yrs
CEO Tenure

Operates as a formulator of material solutions in the United States, Canada, Mexico, Europe, South America, and Asia.